English

ENDOCYTE INC

EDGAR

ECYT Filing (4) · filed 2018-12-21

140 filing records in this dataset, filed from 2010-08-17 to 2018-12-21. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

14.5 thousand Unit12

2018 Q2 · Unit12

Exact inputs and evidence

Revenue: 14465 Unit12 Source

Operating margin

-84,631.95%

2018 Q2 · %

Exact inputs and evidence

Operating Income: -12242011 Unit12 Source
Revenue: 14465 Unit12 Source

Operating cash flow

-11.1 million Unit12

2018 Q2 · Unit12

Exact inputs and evidence

Operating Cash Flow: -18758887 Unit12 Source
Operating Cash Flow: -7705009 Unit12 Source

Free cash flow

-11.1 million Unit12

2018 Q2 · Unit12

Exact inputs and evidence

Operating Cash Flow: -18758887 Unit12 Source
Operating Cash Flow: -7705009 Unit12 Source
Capital Expenditure: 14708 Unit12 Source
Capital Expenditure: 5225 Unit12 Source

Cash and cash equivalents: 67.3 million Unit12 2018-09-30 Source
Exact value

67268340 Unit12
Long-term debt including current maturities: 0 USD 2012-12-31 Source
Exact value

0 USD
Shares outstanding: 81.3 million Unit1 2018-09-30 Source
Exact value

81323300 Unit1

Reported share-count change

69.92% · 33.5 million Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

47859381 Unit1 · 2017-09-30· Source
81323300 Unit1 · 2018-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-12-21.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2017-12-31
Operating income: 4 of 11 periods available· newest 2017-12-31
Net income: 4 of 11 periods available· newest 2017-12-31
Operating cash flow: 4 of 11 periods available· newest 2017-12-31
Capital expenditure: 4 of 11 periods available· newest 2017-12-31
Total assets: 3 of 11 periods available· newest 2017-12-31
Total liabilities: 3 of 11 periods available· newest 2017-12-31
Current assets: 3 of 11 periods available· newest 2017-12-31
Current liabilities: 3 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2017-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2012-12-31
Shares outstanding: 3 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
0%

Prior period

Unit12 70,000

2016-01-01 – 2016-12-31
Current period

Unit12 70,000

2017-01-01 – 2017-12-31

Exact inputs and evidence

70000 − 70000 = 0 Unit12

70000 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
70000 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Year-over-year change in Revenue: 0 Unit12 Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 70000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#1098275 Filing: 000155837018001164 Input fundies:Revenue: 70000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#1097673 Filing: 000155837018001164
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit12 11.18 million

Prior period

−Unit12 43.89 million

2016-01-01 – 2016-12-31
Current period

−Unit12 55.06 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-55064150 − -43887573 = -11176577 Unit12

-43887573 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-55064150 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Year-over-year change in Net income: -11176577 Unit12 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -55064150 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#712610 Filing: 000155837018001164 Input fundies:NetIncome: -43887573 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#711130 Filing: 000155837018001164
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit12 992,101

Prior period

−Unit12 34.65 million

2016-01-01 – 2016-12-31
Current period

−Unit12 33.66 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-33658654 − -34650755 = 992101 Unit12

-34650755 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-33658654 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Year-over-year change in Operating cash flow: 992101 Unit12 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -33658654 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709861 Filing: 000155837018001164 Input fundies:OperatingCashFlow: -34650755 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709669 Filing: 000155837018001164
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-88.4%

Prior period

Unit12 713,839

2016-01-01 – 2016-12-31
Current period

Unit12 82,455

2017-01-01 – 2017-12-31

Exact inputs and evidence

82455 − 713839 = -631384 Unit12

713839 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
82455 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Year-over-year change in Capital expenditure: -631384 Unit12 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 82455 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#738016 Filing: 000155837018001164 Input fundies:CapitalExpenditure: 713839 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#737827 Filing: 000155837018001164
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue Unit12 70,000 100% of revenue
Operating costs Derived Unit12 56.18 million 80,251% of revenue
Operating income −Unit12 56.11 million −80,151% of revenue
Tax, interest and other Derived −Unit12 1.04 million −1,488% of revenue
Net income −Unit12 55.06 million −78,663% of revenue

Cash

Operating cash flow −Unit12 33.66 million −48,084% of revenue
Capital expenditure Unit12 82,455 118% of revenue
Free cash flow Derived −Unit12 33.74 million −48,202% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Net income was higher than operating income, so the split is not drawn.
2015 Operating loss: operating costs were 60,061% of revenue.
2016 Operating loss: operating costs were 63,986% of revenue.
2017 Operating loss: operating costs were 80,251% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	70353483	65326755 Derived	5026728	-432749 Derived	5459477	-43707512 Derived	Source 2014-01-01 – 2014-12-31: 70353483 Unit12 Inspect Revenue Open source 2014-01-01 – 2014-12-31: 5026728 Unit12 Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 5459477 Unit12 Inspect Net Income Open source 2014-01-01 – 2014-12-31: -42205768 Unit12 Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 1501744 Unit12 Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	70000	42042937 Derived	-41972937	-703188 Derived	-41269749	-32559741 Derived	Source 2015-01-01 – 2015-12-31: 70000 Unit12 Inspect Revenue Open source 2015-01-01 – 2015-12-31: -41972937 Unit12 Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -41269749 Unit12 Inspect Net Income Open source 2015-01-01 – 2015-12-31: -32218125 Unit12 Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 341616 Unit12 Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	70000	44790324 Derived	-44720324	-832751 Derived	-43887573	-35364594 Derived	Source 2016-01-01 – 2016-12-31: 70000 Unit12 Inspect Revenue Open source 2016-01-01 – 2016-12-31: -44720324 Unit12 Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -43887573 Unit12 Inspect Net Income Open source 2016-01-01 – 2016-12-31: -34650755 Unit12 Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 713839 Unit12 Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	70000	56176045 Derived	-56106045	-1041895 Derived	-55064150	-33741109 Derived	Source 2017-01-01 – 2017-12-31: 70000 Unit12 Inspect Revenue Open source 2017-01-01 – 2017-12-31: -56106045 Unit12 Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -55064150 Unit12 Inspect Net Income Open source 2017-01-01 – 2017-12-31: -33658654 Unit12 Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 82455 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 70K 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20142014-12-31	Revenue	70353483	Revenue: 70353483 Open source
20152015-12-31	Revenue	70000	Revenue: 70000 Open source
20162016-12-31	Revenue	70000	Revenue: 70000 Open source
20172017-12-31	Revenue	70000	Revenue: 70000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 70353483 Open source
20152015-12-31	Year over year	-99.9%	Revenue: 70000 Open source Revenue: 70353483 Open source
20162016-12-31	Year over year	0%	Revenue: 70000 Open source Revenue: 70000 Open source
20172017-12-31	Year over year	0%	Revenue: 70000 Open source Revenue: 70000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -80,151.5% 2017

Net margin -78,663.1% 2017

Free cash flow margin -48,201.6% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	7.1%	Operating Income: 5026728 Open source Revenue: 70353483 Open source
20152015-12-31	Operating margin	-59,961.3%	Operating Income: -41972937 Open source Revenue: 70000 Open source
20162016-12-31	Operating margin	-63,886.2%	Operating Income: -44720324 Open source Revenue: 70000 Open source
20172017-12-31	Operating margin	-80,151.5%	Operating Income: -56106045 Open source Revenue: 70000 Open source
20142014-12-31	Net margin	7.8%	Net Income: 5459477 Open source Revenue: 70353483 Open source
20152015-12-31	Net margin	-58,956.8%	Net Income: -41269749 Open source Revenue: 70000 Open source
20162016-12-31	Net margin	-62,696.5%	Net Income: -43887573 Open source Revenue: 70000 Open source
20172017-12-31	Net margin	-78,663.1%	Net Income: -55064150 Open source Revenue: 70000 Open source
20142014-12-31	Free cash flow margin	-62.1%	Revenue: 70353483 Open source Operating Cash Flow: -42205768 Open source Capital Expenditure: 1501744 Open source
20152015-12-31	Free cash flow margin	-46,513.9%	Revenue: 70000 Open source Operating Cash Flow: -32218125 Open source Capital Expenditure: 341616 Open source
20162016-12-31	Free cash flow margin	-50,520.8%	Revenue: 70000 Open source Operating Cash Flow: -34650755 Open source Capital Expenditure: 713839 Open source
20172017-12-31	Free cash flow margin	-48,201.6%	Revenue: 70000 Open source Operating Cash Flow: -33658654 Open source Capital Expenditure: 82455 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 -33.7M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20142014-12-31	Operating cash flow	-42205768	Operating Cash Flow: -42205768 Open source
20152015-12-31	Operating cash flow	-32218125	Operating Cash Flow: -32218125 Open source
20162016-12-31	Operating cash flow	-34650755	Operating Cash Flow: -34650755 Open source
20172017-12-31	Operating cash flow	-33658654	Operating Cash Flow: -33658654 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 -33.7M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20142014-12-31	Free cash flow	-43707512	Operating Cash Flow: -42205768 Open source Capital Expenditure: 1501744 Open source
20152015-12-31	Free cash flow	-32559741	Operating Cash Flow: -32218125 Open source Capital Expenditure: 341616 Open source
20162016-12-31	Free cash flow	-35364594	Operating Cash Flow: -34650755 Open source Capital Expenditure: 713839 Open source
20172017-12-31	Free cash flow	-33741109	Operating Cash Flow: -33658654 Open source Capital Expenditure: 82455 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

5.2% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Liabilities / assets	Not reported	No source recorded
20152015-12-31	Liabilities / assets	3.9%	Total Liabilities: 7039440 Open source Total Assets: 178385577 Open source
20162016-12-31	Liabilities / assets	4.4%	Total Liabilities: 6346991 Open source Total Assets: 143494354 Open source
20172017-12-31	Liabilities / assets	5.2%	Total Liabilities: 5278124 Open source Total Assets: 100762269 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

21.68× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Current assets / current liabilities	Not reported	No source recorded
20152015-12-31	Current assets / current liabilities	28.26×	Current Assets: 174875574 Open source Current Liabilities: 6188993 Open source
20162016-12-31	Current assets / current liabilities	25.22×	Current Assets: 140255710 Open source Current Liabilities: 5562174 Open source
20172017-12-31	Current assets / current liabilities	21.68×	Current Assets: 98572803 Open source Current Liabilities: 4546180 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	Unit12 5.46 million Exact value Exact value: 5459477 Unit12 2014-01-01 – 2014-12-31: 5459477 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ENDOCYTE INC · 2014-12-31 ENDOCYTE INC (edgar:1235007) Net Income: 5459477 Unit12 Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 5459477 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837017001674/ecyt-20161231.xml#817337 Filing: 000155837017001674 The citation records this snapshot. The page link may show a newer release later.	−Unit12 42.21 million Exact value Exact value: -42205768 Unit12 2014-01-01 – 2014-12-31: -42205768 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOCYTE INC · 2014-12-31 ENDOCYTE INC (edgar:1235007) Operating Cash Flow: -42205768 Unit12 Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -42205768 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837017001674/ecyt-20161231.xml#816641 Filing: 000155837017001674 The citation records this snapshot. The page link may show a newer release later.	Unit12 1.5 million Exact value Exact value: 1501744 Unit12 2014-01-01 – 2014-12-31: 1501744 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOCYTE INC · 2014-12-31 ENDOCYTE INC (edgar:1235007) Capital Expenditure: 1501744 Unit12 Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 1501744 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837017001674/ecyt-20161231.xml#850652 Filing: 000155837017001674 The citation records this snapshot. The page link may show a newer release later.	−Unit12 43.71 million Calculation and evidence -42205768 − 1501744 Unit12 Exact free cash flow: -43707512 Unit12 2014-01-01 – 2014-12-31: -42205768 Unit12 · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1501744 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOCYTE INC · 2014-12-31 ENDOCYTE INC (edgar:1235007) Free cash flow: -43707512 Unit12 Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -42205768 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837017001674/ecyt-20161231.xml#816641 Filing: 000155837017001674 Input fundies:CapitalExpenditure: 1501744 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837017001674/ecyt-20161231.xml#850652 Filing: 000155837017001674 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−Unit12 41.27 million Exact value Exact value: -41269749 Unit12 2015-01-01 – 2015-12-31: -41269749 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ENDOCYTE INC · 2015-12-31 ENDOCYTE INC (edgar:1235007) Net Income: -41269749 Unit12 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -41269749 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#710053 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 32.22 million Exact value Exact value: -32218125 Unit12 2015-01-01 – 2015-12-31: -32218125 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOCYTE INC · 2015-12-31 ENDOCYTE INC (edgar:1235007) Operating Cash Flow: -32218125 Unit12 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -32218125 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709477 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	Unit12 341,616 Exact value Exact value: 341616 Unit12 2015-01-01 – 2015-12-31: 341616 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOCYTE INC · 2015-12-31 ENDOCYTE INC (edgar:1235007) Capital Expenditure: 341616 Unit12 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 341616 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#737638 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 32.56 million Calculation and evidence -32218125 − 341616 Unit12 Exact free cash flow: -32559741 Unit12 2015-01-01 – 2015-12-31: -32218125 Unit12 · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 341616 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOCYTE INC · 2015-12-31 ENDOCYTE INC (edgar:1235007) Free cash flow: -32559741 Unit12 Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32218125 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709477 Filing: 000155837018001164 Input fundies:CapitalExpenditure: 341616 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#737638 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−Unit12 43.89 million Exact value Exact value: -43887573 Unit12 2016-01-01 – 2016-12-31: -43887573 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ENDOCYTE INC · 2016-12-31 ENDOCYTE INC (edgar:1235007) Net Income: -43887573 Unit12 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -43887573 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#711130 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 34.65 million Exact value Exact value: -34650755 Unit12 2016-01-01 – 2016-12-31: -34650755 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOCYTE INC · 2016-12-31 ENDOCYTE INC (edgar:1235007) Operating Cash Flow: -34650755 Unit12 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -34650755 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709669 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	Unit12 713,839 Exact value Exact value: 713839 Unit12 2016-01-01 – 2016-12-31: 713839 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOCYTE INC · 2016-12-31 ENDOCYTE INC (edgar:1235007) Capital Expenditure: 713839 Unit12 Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 713839 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#737827 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 35.36 million Calculation and evidence -34650755 − 713839 Unit12 Exact free cash flow: -35364594 Unit12 2016-01-01 – 2016-12-31: -34650755 Unit12 · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 713839 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOCYTE INC · 2016-12-31 ENDOCYTE INC (edgar:1235007) Free cash flow: -35364594 Unit12 Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34650755 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709669 Filing: 000155837018001164 Input fundies:CapitalExpenditure: 713839 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#737827 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−Unit12 55.06 million Exact value Exact value: -55064150 Unit12 2017-01-01 – 2017-12-31: -55064150 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Net Income: -55064150 Unit12 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -55064150 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#712610 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 33.66 million Exact value Exact value: -33658654 Unit12 2017-01-01 – 2017-12-31: -33658654 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Operating Cash Flow: -33658654 Unit12 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -33658654 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709861 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	Unit12 82,455 Exact value Exact value: 82455 Unit12 2017-01-01 – 2017-12-31: 82455 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Capital Expenditure: 82455 Unit12 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 82455 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#738016 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.	−Unit12 33.74 million Calculation and evidence -33658654 − 82455 Unit12 Exact free cash flow: -33741109 Unit12 2017-01-01 – 2017-12-31: -33658654 Unit12 · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 82455 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOCYTE INC · 2017-12-31 ENDOCYTE INC (edgar:1235007) Free cash flow: -33741109 Unit12 Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1235007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33658654 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#709861 Filing: 000155837018001164 Input fundies:CapitalExpenditure: 82455 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1235007/000155837018001164/ecyt-20171231.xml#738016 Filing: 000155837018001164 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

140 filings · 2,308 latest values · 2,308 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001235007, 1235007, ECYT, ecyt, edgar:1235007

Also known as ENDOCYTE INC

ENDOCYTE INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation